Significant Ownership of Rock Springs Capital Management LP

Signature - Title
/s/ Mark Bussard - Mark Bussard - Member
Location
Baltimore, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Rock Springs Capital Management LP.

Notify me when Rock Springs Capital Management LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Rock Springs Capital Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TLPH TALPHERA, INC. Common Stock, $0.001 par value 7.9% $1,543,350 3,589,186 Rock Springs Capital Management LP 10 Sep 2025
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 4.7% $7,720,853 5,046,309 Rock Springs Capital Management LP 31 Mar 2025
MREO MEREO BIOPHARMA GROUP PLC Ordinary Shares, nominal value 0.003, per ordinary share 4.2% $87,229,423 33,421,235 Rock Springs Capital Management LP 31 Mar 2025
TVTX Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $53,545,523 -$37,621,463 2,921,196 -41% Rock Springs Capital Management LP 31 Mar 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Rock Springs Capital Management LP 03 Jul 2025
INZY Inozyme Pharma, Inc. Common stock, par value $0.0001 per share 0% $0 0 Rock Springs Capital Management LP 30 Jun 2025
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Rock Springs Capital Management LP 31 Mar 2025

Schedules 13D/G Reported by Rock Springs Capital Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.